Celsius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 07, 2023 at 06:11 am EST
Share
Celsius Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 384.76 million compared to USD 188.23 million a year ago. Net income was USD 83.95 million compared to net loss of USD 181.9 million a year ago. Basic earnings per share from continuing operations was USD 0.3067 compared to basic loss per share from continuing operations of USD 0.82 a year ago. Diluted earnings per share from continuing operations was USD 0.2967 compared to diluted loss per share from continuing operations of USD 0.82 a year ago.
For the nine months, sales was USD 970.58 million compared to USD 475.64 million a year ago. Net income was USD 176.69 million compared to net loss of USD 166.06 million a year ago. Basic earnings per share from continuing operations was USD 0.62 compared to basic loss per share from continuing operations of USD 0.7533 a year ago. Diluted earnings per share from continuing operations was USD 0.6033 compared to diluted loss per share from continuing operations of USD 0.7533 a year ago.
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
CELSIUS HOLDINGS, INC. 
